2GJZ
 
 | |
2GK0
 
 | |
3R08
 
 | |
3R2X
 
 | |
3OB0
 
 | A non-self sugar mimic of the HIV glycan shield shows enhanced antigenicity | 分子名称: | 7-deoxy-L-glycero-alpha-D-manno-heptopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose, Fab 2G12, heavy chain, ... | 著者 | Doores, K.J, Fulton, Z, Hong, V, Patel, M.K, Scanlan, C.N, Wormald, M.R, Finn, M.G, Burton, D.R, Wilson, I.A, Davis, B.G. | 登録日 | 2010-08-06 | 公開日 | 2011-01-12 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.85 Å) | 主引用文献 | A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. Proc.Natl.Acad.Sci.USA, 107, 2010
|
|
3OAU
 
 | Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Non-Domain-Exchanged Forms, but only binds the HIV-1 Glycan Shield if Domain-Exchanged | 分子名称: | Fab 2G12, heavy chain, light chain, ... | 著者 | Doores, K.J, Fulton, Z, Huber, M, Wilson, I.A, Burton, D.R. | 登録日 | 2010-08-05 | 公開日 | 2011-01-12 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged. J.Virol., 84, 2010
|
|
3QL3
 
 | Re-refined coordinates for PDB entry 1RX2 | 分子名称: | Dihydrofolate reductase, FOLIC ACID, MANGANESE (II) ION, ... | 著者 | Bhabha, G, Ekiert, D.C, Wright, P.E, Wilson, I.A. | 登録日 | 2011-02-02 | 公開日 | 2011-04-27 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | A dynamic knockout reveals that conformational fluctuations influence the chemical step of enzyme catalysis. Science, 332, 2011
|
|
2I27
 
 | |
2I24
 
 | |
2I26
 
 | |
6BKM
 
 | |
6BKT
 
 | |
5UF1
 
 | Crystal Structure of Variable Lymphocyte Receptor (VLR) O13 in complex with H-trisaccharide | 分子名称: | CHLORIDE ION, O13, alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | 著者 | Gunn, R.J, Collins, B.C, McKitrick, T.R, Cummings, R.D, Cooper, M.D, Herrin, B.R, Wilson, I.A. | 登録日 | 2017-01-03 | 公開日 | 2017-10-18 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.03 Å) | 主引用文献 | Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates. Structure, 25, 2017
|
|
7KN3
 
 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab | 分子名称: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, S-B8 Fab heavy chain, ... | 著者 | Liu, H, Zhu, X, Wilson, I.A. | 登録日 | 2020-11-04 | 公開日 | 2021-09-22 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.251 Å) | 主引用文献 | Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago. Adv Sci, 9, 2022
|
|
7KN4
 
 | |
5UFC
 
 | Crystal Structure of Variable Lymphocyte Receptor (VLR) Tn4-22 with H-trisaccharide bound | 分子名称: | Tn4-22, alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | 著者 | Collins, B.C, Gunn, R.J, McKitrick, T.R, Cummings, R.D, Cooper, M.D, Herrin, B.R, Wilson, I.A. | 登録日 | 2017-01-04 | 公開日 | 2017-10-18 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.888 Å) | 主引用文献 | Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates. Structure, 25, 2017
|
|
6D0U
 
 | |
5UI4
 
 | Structure of NME1 covalently conjugated to imidazole fluorosulfate | 分子名称: | 4-[4-(3-methoxyphenyl)-1-(prop-2-yn-1-yl)-1H-imidazol-5-yl]phenyl sulfurofluoridate, Nucleoside diphosphate kinase A | 著者 | Mortenson, D.E, Brighty, G.J, Wilson, I.A, Kelly, J.W. | 登録日 | 2017-01-12 | 公開日 | 2018-01-17 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.75 Å) | 主引用文献 | "Inverse Drug Discovery" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates. J. Am. Chem. Soc., 140, 2018
|
|
6CF7
 
 | |
6CXL
 
 | anti-HIV-1 Fab 2G12 in complex with glycopeptide 10F5 | 分子名称: | alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose, anti-HIV-1 Fab 2G12 heavy chain, anti-HIV-1 Fab 2G12 light chain | 著者 | Stanfield, R.L, Wilson, I.A. | 登録日 | 2018-04-03 | 公開日 | 2019-02-20 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (3.586 Å) | 主引用文献 | Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities. ACS Cent Sci, 5, 2019
|
|
6D2P
 
 | |
1ES0
 
 | |
5UM8
 
 | Crystal structure of HIV-1 envelope trimer 16055 NFL TD CC (T569G) in complex with Fabs 35022 and PGT124 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Fab 35022 heavy chain, ... | 著者 | Garces, F, Stanfield, R.L, Wilson, I.A. | 登録日 | 2017-01-26 | 公開日 | 2017-05-24 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (3.935 Å) | 主引用文献 | Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein. Immunity, 46, 2017
|
|
6CXG
 
 | anti-HIV-1 Fab 2G12 in complex with glycopeptide 10V1S | 分子名称: | 10V1S glycopeptide, GLYCEROL, alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose, ... | 著者 | Stanfield, R.L, Wilson, I.A. | 登録日 | 2018-04-03 | 公開日 | 2019-02-20 | 最終更新日 | 2023-10-04 | 実験手法 | X-RAY DIFFRACTION (2.298 Å) | 主引用文献 | Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities. ACS Cent Sci, 5, 2019
|
|
5V2A
 
 | Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9) | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Heavy chain of H7.167 antibody, Hemagglutinin, ... | 著者 | Zhang, H, Zhu, X, Wilson, I.A. | 登録日 | 2017-03-03 | 公開日 | 2017-04-05 | 最終更新日 | 2024-11-20 | 実験手法 | X-RAY DIFFRACTION (4.656 Å) | 主引用文献 | H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. J. Clin. Invest., 126, 2016
|
|